Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis.

doi:10.1016/s0165-5728(97)00161-6

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis.

Journal of neuroimmunology - 1 Jan 1998

Huang D, Pirskanen R, Hjelmström P, Lefvert A K

Abstract excerpt

Interleukin 1 (IL-1)beta, TaqI restriction fragment length polymorphism (RFLP) in exon 5 and IL-1 receptor antagonist (IL-1Ra) polymorphism, variable numbers of an 86-bp tandem repeat (VNTR), were analysed in 107 patients with myasthenia gravis (MG) and 82 ethnically matched healthy control (HC)...

Topics

Adult
Alleles
Autoimmune Diseases
Case-Control Studies
Deoxyribonucleases, Type II Site-Specific
Disease Susceptibility
Female
Genetic Markers
Genotype
HLA-B8 Antigen
Humans
Interleukin 1 Receptor Antagonist Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Male

Middle Aged

Minisatellite Repeats

Myasthenia Gravis

Polymorphism, Restriction Fragment Length

Sialoglycoproteins

Source

Open in PubMed

Identifiers

PMID: 9521608
DOI: 10.1016/s0165-5728(97)00161-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9521608-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis.PMID 9521608Read ↗

Graves' ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist.Semantic proximity Read ↗

IL-1 genes in myasthenia gravis: IL-1A -889 polymorphism associated with sex and age of disease onset.Semantic proximity Read ↗

Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease.Semantic proximity Read ↗

A novel galectin-1 and interleukin 2 receptor β haplotype is associated with autoimmune myasthenia gravis.Semantic proximity Read ↗

Cytokines Single Nucleotide Polymorphisms (SNPs) Association With Myasthenia Gravis (MG) In Algerian Patients: A Case-Control Study On A Small Group.Semantic proximity Read ↗

Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene.Semantic proximity Read ↗

Genetics of myasthenia gravis: a case-control association study in the Hellenic population.Semantic proximity Read ↗

Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: implications of diverse effects of IL-10 in the pathogenesis of the disease.Semantic proximity Read ↗

A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis.Semantic proximity Read ↗

Association of the Fc gamma receptor IIA-R/R131 genotype with myasthenia gravis in Dutch patients.Semantic proximity Read ↗

Association of HLA Class II Alleles with Disease Severity and Treatment Response in Iranian Patients with Myasthenia GravisSemantic proximity Read ↗

Interleukin-10 promoter polymorphisms in myasthenia gravis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.